# ST-Elevation Myocardial Infarction (STEMI) Management

## Diagnosis
- ECG: ST elevation ≥1mm in 2 contiguous leads, or new LBBB
- Biomarkers: Troponin elevation (may be normal early)
- Symptoms: Chest pain/pressure, diaphoresis, dyspnea, nausea

## Immediate Management (Door-to-Balloon <90 min)
- **Aspirin** 325mg chewed immediately
- **P2Y12 inhibitor**: Ticagrelor 180mg or Clopidogrel 600mg loading
- **Anticoagulation**: Unfractionated heparin bolus + infusion
- **Primary PCI** is preferred reperfusion strategy if available within 120 min of first medical contact
- **Fibrinolysis** if PCI not available within 120 min: tenecteplase (weight-based), alteplase, or reteplase; door-to-needle <30 min

## Contraindications to Fibrinolysis
- Active internal bleeding (excluding menses)
- Prior hemorrhagic stroke at any time
- Ischemic stroke within 3 months
- Intracranial neoplasm, AVM, or aneurysm
- Known active bleeding or bleeding diathesis
- Significant head/facial trauma within 3 months
- Suspected aortic dissection

## Adjunctive Therapy
- **Beta-blocker**: Metoprolol — start within 24 hours if no contraindications (avoid in cardiogenic shock, decompensated HF, heart block)
- **ACE inhibitor/ARB**: Start within 24 hours if anterior MI, HF, or EF ≤40%
- **Statin**: High-intensity (Atorvastatin 80mg or Rosuvastatin 20mg)
- **Nitrates**: For ongoing ischemia (avoid if RV infarct, hypotension, PDE5 inhibitor use)
- **Morphine**: Only if pain uncontrolled with nitrates

## Post-MI Care
- Dual antiplatelet therapy (DAPT): 12 months minimum after stent
- Cardiac rehabilitation referral
- Echocardiogram to assess LV function
- Risk factor modification: smoking cessation, lipid management, BP control, diabetes management
- Follow-up: 2-6 weeks post-discharge

## Complications to Monitor
- Cardiogenic shock, mechanical complications (free wall rupture, VSD, papillary muscle rupture)
- Arrhythmias (VT/VF, heart block), pericarditis, LV thrombus
